Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities
Karen D. Davis(University Health Network), Mary Ann Pelleymounter(Amgen (United States)), Tor D. Wager(University of Colorado Boulder), Michael J. Iadarola(National Institutes of Health Clinical Center), Christin Veasley, Martin S. Angst(Stanford Medicine), Georgene W. Hergenroeder(The University of Texas Health Science Center at Houston), Joachim Scholz(Harvard University), Jiang‐Ti Kong(Stanford University), Nima Aghaeepour(Stanford Medicine), Brice Gaudillière(Stanford Medicine), Irene Tracey(University of Oxford), Christopher Crean, Robert R. Edwards(Brigham and Women's Hospital), Yunyun Jiang(Milken Institute), Ashley Brenton(Path BioAnalytics (United States)), Ajay D. Wasan(University of Pittsburgh), Christine N. Sang(Massachusetts General Hospital), Andrew H. Ahn(Teva Pharmaceuticals (United States)), Michael E. Burczynski(Teva Pharmaceuticals (United States)), Carl Y. Saab(Allen Institute for Brain Science), David Borsook(Harvard University), Jing Wang(NYU Langone Health), Märta Segerdahl, Smriti Iyengar(National Institute of Neurological Disorders and Stroke), Sean Mackey(Stanford University)
Cited by 504
Related Papers
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science
|The Lancet Psychiatry|2020|6k
Effects of the <i>obese</i> Gene Product on Body Weight Regulation in <i>ob</i> / <i>ob</i> Mice
|Science|1995|4k
A meta-analysis of heart rate variability and neuroimaging studies: Implications for heart rate variability as a marker of stress and health
|Neuroscience & Biobehavioral Reviews|2011|3.1k
A classification of chronic pain for ICD-11
|Pain|2015|2.8k